Live Breaking News & Updates on Vigil Neuroscience Company Profile

Stay updated with breaking news from Vigil neuroscience company profile. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Vigil Neuroscience (NASDAQ:VIGL) Given "Buy" Rating at HC Wainwright

HC Wainwright reissued their buy rating on shares of Vigil Neuroscience (NASDAQ:VIGL – Get Rating) in a research note issued to investors on Wednesday, Benzinga reports. The firm currently has a $24.00 price target on the stock. HC Wainwright also issued estimates for Vigil Neuroscience’s Q1 2023 earnings at ($0.45) EPS, Q2 2023 earnings at […] ....

United States , Vanguard Group Inc , Morgan Stanley , America Corp , Barclays Plc , Vigil Neuroscience Company Profile , Vigil Neuroscience Inc , Vigil Neuroscience , Get Rating , Street Corp , Vanguard Group , Vigil Neuroscience Daily , Nasdaq Vigl , Reiterated Rating , Hc Wainwright ,

Vigil Neuroscience (NASDAQ:VIGL) Receives "Buy" Rating from HC Wainwright

HC Wainwright reaffirmed their buy rating on shares of Vigil Neuroscience (NASDAQ:VIGL – Get Rating) in a research report sent to investors on Wednesday morning, Benzinga reports. HC Wainwright currently has a $24.00 price objective on the stock. HC Wainwright also issued estimates for Vigil Neuroscience’s Q1 2023 earnings at ($0.45) EPS, Q2 2023 earnings […] ....

Blackrock Inc , Vigil Neuroscience Company Profile , Vigil Neuroscience Inc , York Mellon Corp , Citigroup Inc , Vanguard Group Inc , Charles Schwab Investment Management Inc , Vigil Neuroscience , Get Rating , New York Mellon Corp , Charles Schwab Investment Management , Vigil Neuroscience Daily , Nasdaq Vigl , Reiterated Rating , Hc Wainwright ,

FY2026 EPS Estimates for Vigil Neuroscience, Inc. (NASDAQ:VIGL) Reduced by Analyst

Vigil Neuroscience, Inc. (NASDAQ:VIGL – Get Rating) – Equities research analysts at HC Wainwright decreased their FY2026 earnings per share estimates for Vigil Neuroscience in a research report issued to clients and investors on Wednesday, March 22nd. HC Wainwright analyst A. Fein now expects that the company will post earnings of $0.76 per share for […] ....

Vigil Neuroscience Company Profile , Vigil Neuroscience Inc , York Mellon Corp , Citigroup Inc , Vanguard Group Inc , Blackrock Inc , Charles Schwab Investment Management Inc , Vigil Neuroscience , Get Rating , New York Mellon Corp , Charles Schwab Investment Management , Vigil Neuroscience Daily , Nasdaq Vigl , Earnings Estimates , Hc Wainwright ,